3Okazaki I, Watanabe, T, Hozawa S, et al. Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery,Keio J Med ,2001,50(2) :58-65.
4Jonker AM, Dijkhuis F, Hardonk M J, et al. Immunohistochemical study of hepatic fibrosis induced in rats by multiple galactosamine injections. Hepatology, 1994,19 (3) : 775- 781.
6Murawaki Y, Koda M, Okamoto K, et al. Diangostic value of serum type Ⅳ collagen test in cormparison with platelet count for predicating the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol, 2001, 16:777～781
7Boeker KH, Haberkom CI, Michels D, et al. Diagnostic potential of circulating TIMP-1 and MMP-1 as makers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta, 2002, 316:71 ～78
8Flisisak R, Maxwell P, Prokopowicz D, et al. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta-1 possible non - invasive biomarkers of hepatic fibrosis in patient with chronic B and C hepatitis. Hepatogastroenterology, 2002, 49:1369～ 1372
9Mccaffery AP, nakia H, Pandey K, et al. Inhibition of hepatitis B virus in micebyinterference. Nat Biotechnol, 2003, 21:639～644
10Hirata M, Akbar SM, Horiike N, et al. Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virue. Eur J Clin Invest, 2001, 31:528～535
